Latest Europe News

Bioxyne Limited has secured import permits and purchase orders worth A$5.1 million for medical cannabis in Germany, signaling strong early traction in a key European market.

AVITA Medical has secured the CE Mark for its innovative RECELL GO device, paving the way for commercialization across key European markets including Germany, Italy, and the UK. This regulatory milestone expands the company’s footprint in acute wound care.

Altamin Limited has been awarded a A$3.62 million refundable grant to advance its Lazio project in Italy, aiming to develop an innovative geothermal-powered process for extracting critical raw materials like lithium, boron, and sulphate of potash.

Vulcan Energy has gained City of Landau Council approval to acquire land for its pioneering geothermal and lithium extraction plant, marking a crucial step toward sustainable energy and lithium supply in Europe.

Carnegie Clean Energy has successfully raised $2.116 million through a Share Purchase Plan, fueling key wave energy projects and global business development efforts.

Vulcan Energy has obtained the crucial permit to build and operate its Central Lithium Plant in Frankfurt, marking a significant milestone in Europe's push for sustainable, domestic lithium production to support electric vehicle battery manufacturing.

SportsHero has expanded its partnership with Indonesian telecom giant Indosat to include a new mobile casual gaming product, aiming to capture a vast and growing mobile gamer audience in Southeast Asia.

Ariana Resources plc is set to raise up to A$15 million through a dual listing on the ASX, aiming to accelerate development at its flagship Dokwe Gold Project in Zimbabwe and repay existing debt. The capital raising also supports ongoing operations and exploration across its diverse portfolio in Türkiye, Kosovo, and Cyprus.

Krakatoa Resources has deployed a second drill rig at its Zopkhito antimony-gold project in Georgia, accelerating efforts to convert historical resource estimates into a JORC-compliant Mineral Resource.

Orthocell Limited reports an 81.1% overall treatment success rate from its Remplir Real World Evidence study, reinforcing the product’s safety and efficacy as it expands sales in the US and prepares regulatory submissions for the EU and UK.

Proteomics International has unveiled new clinical data confirming its PromarkerEso blood test can accurately detect early stages of esophageal adenocarcinoma, potentially transforming screening for a cancer with poor prognosis.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.